Mov Disord Vol 33, Suppl 2 Archives - Page 116 of 177 - MDS Abstracts

2018 International Congress
Neuropsychological characteristics of children with tremor
S. O'Shea, W. Garcia, E. Louis, R. Alcalay, V. Rauh (New York, NY, USA)
Objective: To test if otherwise healthy children with tremor have neuropsychological impairment. Background: Tremor in children has not been as widely studied as tremor in…
2018 International Congress
Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed parkinsonian rats: Implications for learning and memory
E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)
Objective: In the present study, we investigated the effects of reduced DA presence in the PFC on cognitive function and whether treatment with Fluvoxamine maleate…
2018 International Congress
Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease
K. Ohta, T. Nakajima (Niigata, Japan)
Objective: To examine the cerebral blood flow pattern of patients of Parkinson's disease with olfactory disorders, and to investigate the correlation between olfactory impairment and…
2018 International Congress
Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats
S. Singh (Moga, India)
Objective: (1) Curcumin is well tolerated curcuminoid used as supplement for various disorders but problem is its low oral bioavailability. (2) Piperine is combined to…
2018 International Congress
Cognitive Impairment and Depression in Patients with Parkinson’s Disease
XD. Qu, SS. Li (Lanzhou, China)
Objective: To evaluate cognitive impairment and depression in patients with Parkinson's Disease (PD) and its relationship. Background: Patients with Parkinson's disease are prone to cognitive…
2018 International Congress
Distinct networks contribute to the dysexecutive and posterior cortical cognitive syndromes of cognitive impairment in Parkinson’s Disease
S. Lang, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, P. Bellec, O. Monchi (Calgary, AB, Canada)
Objective: The objective of the current study is to relate the network degeneration and the dual syndrome hypothesis of cognitive impairment in Parkinson’s Disease (PD).…
2018 International Congress
Integrated whole exome sequencing and chromosomal microarray in familial Parkinson’s disease
L. Robak, R. Du, B. Yuan, S. Gu, Z. Akdemir, J. Jankovic, J. Lupski, J. Shulman (Houston, TX, USA)
Objective: To determine whether whole exome sequencing (WES) plus chromosomal microarray analysis (CMA) yield a genetic etiology in a cohort of 110 individuals with familial…
2018 International Congress
Nucleotide repeats as genetic risk factors in a Swedish Parkinson’s disease cohort
J. Laffita Mesa, L. Brodin, P. Svenningsson (Stockholm, Sweden)
Objective: To search for abnormal NRE in the following genes: ATXN2, ATXN3, CACNA1A, TBP, c9orf72, PRNP, POLG1A and TOMM40 in a Swedish PD cohort. Background:…
2018 International Congress
Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
YL. Tang, J. Wang (Shanghai, China)
Objective: The aims of the present study were to profile the expression of microRNA29 family (miR-29s) in blood serum from patients with PD vs unaffected…
2018 International Congress
Association of GBA polymorphisms and mutations with dementia in Parkinson disease: A 7-year study of three population-based incident cohorts
K. Lunde, J. Chung, I. Dalen, K. Pedersen, J. Linder, M. Domellöf, E. Elgh, A. Macleod, C. Tzoulis, J. Larsen, O. Tysnes, L. Forsgren, C. Counsell, G. Alves, J. Maple-Grødem (Stavanger, Norway)
Objective: To study the effect of GBA variants on dementia in three deeply phenotyped population-based prospective cohorts of patients with incident Parkinson disease. Background: Dementia…